1 INTRODUCTION

Today the modern world is facing an unprecedented health crisis. The COVID‐19 pandemic is putting extensive strain on healthcare systems hospitals and medical workers worldwide. Epidemiological data are emerging that COVID‐19 patients with cardiac risk factors or pre‐existing cardiac conditions are at increased risk for complications and mortality from COVID‐19. As we just begin to understand the pathophysiology underlying the disease the involvement of the heart whether through direct myocardial infection and damage or due to cardiac complications is already evident. Also the current therapy for COVID‐19 using antiviral agents (hydroxy)chloroquine and other off‐label used medications is not without risk for cardiac side effects. Furthermore the pandemic puts stress on the organization of cardiac health care both for COVID‐19 patients and for the acute and chronic care of cardiac patients in which patient as well as physician‐related delays in treatment could potentially lead to harm.

中文翻译：

---

COVID-19 大流行期间新出现的心脏病问题。

1 简介

今天，现代世界正面临前所未有的健康危机。COVID-19 大流行给全球医疗保健系统医院和医务人员带来了巨大压力。流行病学数据表明，有心脏危险因素或已有心脏病的 COVID-19 患者因 COVID-19 并发症和死亡的风险增加。当我们刚刚开始了解该疾病的病理生理学时，无论是通过直接的心肌感染和损伤还是由于心脏并发症，心脏的受累已经很明显了。此外，目前使用抗病毒剂（羟基）氯喹和其他标签外使用的药物治疗 COVID-19 并非没有心脏副作用的风险。